EP2432530A1 — Dry-powder inhaler
Assigned to Norton Healthcare Ltd · Expires 2012-03-28 · 14y expired
What this patent protects
An inhaler (101) for delivering dry-powder medicament to a patient from an open blister pocket (3) of a blister pack (1). The blister pack (1) has a plurality of blister pockets (3) spaced apart in a length direction of the pack (1) and each containing a measured dose of the medi…
USPTO Abstract
An inhaler (101) for delivering dry-powder medicament to a patient from an open blister pocket (3) of a blister pack (1). The blister pack (1) has a plurality of blister pockets (3) spaced apart in a length direction of the pack (1) and each containing a measured dose of the medicament. The inhaler (101) comprises a housing (103, 105) for enclosing used and unused portions of the blister pack (1) together with a medicament dispensing mechanism (119) for opening the blister pockets (3) of the blister pack (1). The inhaler (101) also comprises a manifold through which air can be drawn in use of the inhaler (101), the manifold comprising an air inlet (125) for receiving external air, at least one medicament aperture (127) for communicating with an opened pocket (3) of the blister pack (1) to enable entrainment of the medicament by the air drawn through the manifold, and an air outlet (129) for delivery of the entrained medicament to the patient.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.